-
JC-1 Mitochondrial Membrane Potential Assay Kit: Applied Wor
2026-07-21
Unlock sensitive, quantitative mitochondrial membrane potential analysis with the JC-1 Mitochondrial Membrane Potential Assay Kit. This guide delivers optimized workflows, troubleshooting strategies, and translational applications that accelerate apoptosis and mitochondrial function studies—empowering researchers to build on the latest immunomodulatory discoveries.
-
Light-Inducible RNA-Releasing Proteins for Precision Gene Th
2026-07-21
A recent study presents a rationally engineered light-inducible RNA-releasing protein (LIRP) that enables reversible, spatiotemporal control of gene expression at the translational level. This approach advances optogenetic gene therapy, offering on-demand regulation and increased safety for applications in metabolic and retinal diseases.
-
Reserpine (N1867): Technical Guidance for Laboratory Researc
2026-07-20
Reserpine (SKU N1867) is a high-purity research compound designed for studies on neurotransmitter depletion, antihypertensive mechanisms, and neuropharmacology. Its workflow depends on strict control of solubility and storage parameters, making it unsuitable for clinical, diagnostic, or veterinary use. Researchers benefit from its well-characterized properties but must avoid long-term solution storage and adhere to laboratory best practices.
-
Bestatin-Based Dissection of Jasmonate Signaling in Arabidop
2026-07-20
This study pioneers a chemical genetics approach using bestatin, an aminopeptidase inhibitor, to dissect jasmonate (JA) signaling in Arabidopsis. By isolating and characterizing bestatin-resistant mutants, the research identifies new genetic loci involved in JA-mediated defense and development, providing valuable insights into plant hormone signaling.
-
Discovery of Benzenesulfonanilide HDAC Inhibitors for Colon
2026-07-19
This study presents the identification and mechanistic evaluation of tertiary benzenesulfonanilide chemotypes as selective HDAC inhibitors for colon cancer therapy. Through an integrated computational and biological approach, the authors reveal a promising HDAC6-selective inhibitor with potent antitumor activity and provide a foundation for developing next-generation epigenetic therapeutics.
-
Piezo1 Drives PANoptosis in Cardiac Ischaemia/Reperfusion In
2026-07-18
This study reveals that the mechanosensitive ion channel Piezo1 intensifies myocardial ischaemia/reperfusion (I/R) injury by activating caspase-8-mediated PANoptosis in cardiomyocytes. The findings highlight a new mechanistic link between Piezo1 and regulated cell death, suggesting Piezo1 as a potential therapeutic target for ischaemic heart disease.
-
Geneticin, G-418 Sulfate: Robust Selection and Antiviral Pre
2026-07-17
This article explores real laboratory scenarios where Geneticin, G-418 Sulfate (SKU A2513) offers proven solutions for cell viability assays, genetic engineering, and antiviral research. We examine its validated performance, data-backed selectivity, and practical advantages for biomedical workflows, aligning evidence with hands-on recommendations for researchers.
-
Dynamics of Carbapenemase Genes in CREC during COVID-19 in C
2026-07-17
This study characterizes the distribution and transmission of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China, during the COVID-19 pandemic. The findings highlight the prevalence of blaNDM-1, multidrug resistance, and the role of mobile genetic elements in rapid gene dissemination, informing future surveillance and resistance mitigation strategies.
-
Z-VAD-FMK in Apoptosis Inhibition: Protocols & Advanced Use-
2026-07-16
Z-VAD-FMK empowers researchers with robust, irreversible pan-caspase inhibition, enabling precise dissection of apoptotic and lytic cell death pathways across diverse models. This guide translates cutting-edge findings into actionable protocols, troubleshooting strategies, and experimental enhancements for apoptosis and immune signaling studies.
-
Gastroretentive Alfuzosin HCl Sponges: MRI-Tracked Release O
2026-07-16
This study presents the development of low-density, gastroretentive sponges loaded with Alfuzosin HCl, aiming to optimize sustained drug release and oral bioavailability for benign prostatic hyperplasia therapy. Using MRI in healthy volunteers, the research demonstrates prolonged gastric retention and superior mucoadhesive properties, particularly for chitosan-based systems, providing new evidence for targeted delivery strategies.
-
Sulfo-NHS-Biotin: Precision Protein Labeling for Surface Ass
2026-07-15
Sulfo-NHS-Biotin offers unmatched selectivity for cell surface protein labeling, streamlining workflows in affinity chromatography, immunoprecipitation, and diagnostics. This guide details experimental best practices, advanced assay integration, and troubleshooting strategies to maximize reproducibility and data quality.
-
AP20187: Chemical Inducer of Dimerization in Tumor Microenvi
2026-07-15
AP20187 enables precision control over protein interactions, revolutionizing workflows in regulated cell therapy and tumor microenvironment studies. Its high solubility and validated in vivo efficacy empower advanced experimental designs for dissecting stromal cell function in cancer models.
-
Co-targeting BRD4 and RAC1 Disrupts Epigenetic Drivers in Br
2026-07-14
The referenced study demonstrates that combined inhibition of BRD4 and RAC1 effectively suppresses growth, stemness, and tumorigenesis in multiple breast cancer subtypes by disrupting the c-MYC–G9a–FTH1 axis and downregulating HDAC1. These findings reveal a promising epigenetic strategy for targeting aggressive breast cancers and inform the design of combinatorial therapies involving chromatin modifiers.
-
20-HETE, TRPV1, and MrgprA3+ Neurons in Chronic Dermatitis I
2026-07-14
This study uncovers the role of the arachidonic acid metabolite 20-HETE in mediating TRPV1 activation, driving allokinesis and chronic itch via MrgprA3+ sensory neurons in chronic dermatitis. By dissecting the interplay between pain and itch signaling, the research identifies new cellular and molecular targets for alleviating chronic dermatitis-associated pruritus.
-
Flumequine as a Precision DNA Topoisomerase II Inhibition Pr
2026-07-13
Explore how Flumequine, a potent DNA topoisomerase II inhibitor, empowers precise in vitro research on DNA replication and cancer mechanisms. Uncover practical assay strategies and new insights grounded in advanced drug response evaluation.